Skip to Main Content

Author Details

Steven G Deeks
University of California san francisco
1988
679
126
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36711855High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against <i>M. tuberculosis</i> antigen.bioRxiv2024
36711855High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against <i>M. tuberculosis</i> antigen.bioRxiv2024
34493840Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).Gene Ther2023
36226414Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States.AIDS Res Hum Retroviruses2023
36089700Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.J Infect Dis2023
37848036Serotonin reduction in post-acute sequelae of viral infection.Cell2023
37667052SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).Nat Immunol2023
38019897A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.PLoS Pathog2023
37910505The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency.Cell Rep2023
37723351Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).Nat Immunol2023
37988251The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.J Med Virol2023
37783718Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence.Nat Commun2023
37961239Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection.medRxiv2023
37957382Viral and host mediators of non-suppressible HIV-1 viremia.Nat Med2023
37682714Comprehensive synergy mapping links a BAF- and NSL-containing "supercomplex" to the transcriptional silencing of HIV-1.Cell Rep2023
36717718Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.Nat Microbiol2023
37344551Prevention, treatment and cure of HIV infection.Nat Rev Microbiol2023
37034605Viral and Host Mediators of Non-Suppressible HIV-1 Viremia.medRxiv2023
37468623A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.Nature2023
36776833Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4.Front Immunol2023
36712077Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection.bioRxiv2023
37205522Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIV.medRxiv2023
37463049The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.J Clin Invest2023
37205470SIV clearance from neonatal macaques following transient CCR5 depletion.bioRxiv2023
36705269Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022.J Infect Dis2023
36881933Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy.J Infect Dis2023
37443365Impact of misclassified defective proviruses on HIV reservoir measurements.Nat Commun2023
37382276Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis.EMBO J2023
36695358Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.AIDS2023
37119030SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.Am J Epidemiol2023
37058141A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design.J Exp Med2023
37056754Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.Front Immunol2023
36798288Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients.medRxiv2023
36798286Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2.bioRxiv2023
36541802Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control.J Virol2023
36541637Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV.AIDS2023
37352211Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.PLoS One2023
37166076Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019.J Infect Dis2023
36599978HIV silencing and cell survival signatures in infected T cell reservoirs.Nature2023
36454631Chronic viral coinfections differentially affect the likelihood of developing long COVID.J Clin Invest2023
37515292Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA.Viruses2023
36596305Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.Cell Host Microbe2023
34493840Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).Gene Ther2023
34584245Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).Gene Ther2023
38019897A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.PLoS Pathog2023
37667052SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).Nat Immunol2023
37910505The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency.Cell Rep2023
37961239Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection.medRxiv2023
37957382Viral and host mediators of non-suppressible HIV-1 viremia.Nat Med2023
37848036Serotonin reduction in post-acute sequelae of viral infection.Cell2023
  • 1 - 50 of 1,358

Recommended Authors

National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2015
Number of shared co-authors 14
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 3
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 3
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 7
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 1
Emory University
Career Start Year 2004
Number of shared co-authors 6
Noguchi Memorial Institute for Medical Research, University of Ghana
Career Start Year 2004
Number of shared co-authors 1
Goethe University Frankfurt, University Hospital
Career Start Year 2003
Number of shared co-authors 5
National Institute of Allergy and Infectious Diseases
Career Start Year 2001
Number of shared co-authors 14
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 12
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 14
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 10
Duke Clinical Research Institute and Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 8
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 25
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 13
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 11
University Hospital of Modena Policlinico, University of Modena and Reggio Emilia
Career Start Year 1995
Number of shared co-authors 12
Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 22
Vanderbilt University Medical Center
Career Start Year 1992
Number of shared co-authors 18
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 12
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 16
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 9
Sacramento Medical Center, Kaiser Permanente Northern California
Career Start Year 1988
Number of shared co-authors 8
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 12
VA Medical Center
Career Start Year 1986
Number of shared co-authors 6
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 6
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 6
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 7
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 4
University of California San Diego
Career Start Year 1975
Number of shared co-authors 14

Collaborators

Co-authored papers 203
Co-authored papers 139
Co-authored papers 83
University of California san francisco
Co-authored papers 60
Co-authored papers 57
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Co-authored papers 37
Vitalant Research Institute
Co-authored papers 36
University of California San Francisco
Co-authored papers 32
Co-authored papers 29
Co-authored papers 28
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 27
Ragon Institute of Mass General
Co-authored papers 26
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 25
Co-authored papers 22
Johns Hopkins University School of Medicine
Co-authored papers 21
Center for AIDS Research, University of California San Diego
Co-authored papers 20
VA Connecticut Healthcare System
Co-authored papers 20
Vitalant Research Institute, USA University of California san francisco
Co-authored papers 19
Co-authored papers 17
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 17
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Co-authored papers 15
University of Alabama at Birmingham
Co-authored papers 15
Co-authored papers 14
Vitalant Research Institute
Co-authored papers 13
Vitalant Research Institute
Co-authored papers 13
Co-authored papers 13
Co-authored papers 13
Frederick National Laboratory
Co-authored papers 12
University of Washington
Co-authored papers 12
Co-authored papers 12